MedPath

Portal Blood Flushes in the Peri-Reperfusion Stage of Liver Transplantation

Completed
Conditions
Liver Disease
Registration Number
NCT03563404
Lead Sponsor
Medical University of South Carolina
Brief Summary

By showing that increased levels of acidotic metabolites and electrolytes in the systemic blood of patients who do not receive portal blood flush prior to reperfusion compared to patients who do receive portal blood flush, and that these increased levels correlate with cardiac depression as seen on TEE, the investigators hope to find a superior technique for liver reperfusion.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Liver Transplantation
  • 18 years old or older
Read More
Exclusion Criteria
  • None
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hemodynamic Stability5 days

The primary objective of this study is to determine whether or not a portal blood flush is useful for maintaining hemodynamic stability in the peri-reperfusion stage of Orthotopic Liver Transplantation as evidence by TEE.

Secondary Outcome Measures
NameTimeMethod
correlation between the cardiac dysfunction and the degree of hyperkalemia seen after reperfusion.5 days

The secondary objective is to determine if there is a correlation between cardiac dysfunction as measured by a qualitative analysis of TEE and the degree of hyperkalemia measured by a post reperfusion blood sample.

Trial Locations

Locations (1)

Medical University of South Carolina

🇺🇸

Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath